Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04526769 · ClinicalTrials.gov registry record
Detecting SARS-CoV-2 in Tears
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 7
- Enrollment target
NCT04526769: Completed study, sponsored by University of Minnesota.
NCT04526769 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04526769 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
Purpose: * To determine the presence of SARS-CoV-2 in tears * To determine SARS-CoV-2 receptors in tear production system
Primary Outcome
Outcome is reported as the percent of tear samples that test either "positive", "negative", or "indeterminant" for SARS-CoV-2 Virus presence.
Interventions
- DIAGNOSTIC_TEST Tear Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2021-12-30 |
What the finished NCT04526769 record still lists
NCT04526769 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tear Collection is the first listed.
NCT04526769 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04526769 about?
NCT04526769 is a clinical study titled "Detecting SARS-CoV-2 in Tears". Purpose: * To determine the presence of SARS-CoV-2 in tears * To determine SARS-CoV-2 receptors in tear production system
What is the current status of trial NCT04526769?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2021-09-01. Estimated completion is 2021-12-30.
What interventions are being tested in trial NCT04526769?
The interventions under investigation include: Tear Collection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04526769?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI